Elvitegravir Synthesis Selective Halogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing elvitegravir face challenges such as inefficient halogenation of 2,4-dimethoxyacetophenone, leading to the formation of dihalogenated derivatives and unsuitable reaction conditions, which complicate the synthesis of key intermediates.
Innovation Solution
A method involving the halogenation of 2,4-dimethoxyacetophenone in a mixture of acetonitrile at low temperatures, followed by reaction with dialkyl carbonates in the presence of strong bases to form benzoyl acetates, and subsequent conversion with (S)-(+)-valinol to produce intermediates, which are then used to synthesize elvitegravir through a quinolone skeleton.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If halogenation of 2,4-dimethoxyacetophenone is performed under conventional conditions, then the reaction proceeds, but dihalogenated derivatives are formed and the synthesis is complicated
Solution Approach 1:
The patent applies parameter changes by carefully controlling the halogenation reaction conditions, specifically using a controlled addition of halogenating agent to 2,4-dimethoxyacetophenone in a suitable solvent at controlled temperature. This parameter optimization ensures selective monohalogenation at the desired position while preventing over-halogenation, thus resolving the contradiction between achieving the desired product and avoiding harmful dihalogenated by-products.
2Productivity
If conventional synthesis methods are used, then elvitegravir can be produced, but the yield and purity of intermediates are reduced
Solution Approach 1:
The patent applies preliminary action by performing the halogenation step with optimized conditions before proceeding to subsequent reactions. By pre-establishing the correct halogenated intermediate with high purity through controlled monohalogenation, the foundation for high yield and purity in subsequent steps is laid, avoiding the need for extensive purification later and improving overall productivity.
3Ease of manufacture
If conventional halogenation conditions are used, then the reaction can proceed, but the reaction conditions are unsuitable and synthesis is complicated
Solution Approach 1:
The patent simplifies the synthesis procedure by optimizing the halogenation parameters including solvent selection, temperature control, and stoichiometric control of the halogenating agent. These parameter changes make the reaction conditions more suitable and easier to control, reducing the complexity of the overall synthesis procedure while maintaining high selectivity for the desired monohalogenated product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves the yield and purity of intermediates, reducing the formation of by-products and enabling a more efficient synthesis of elvitegravir by optimizing reaction conditions and using commercially available starting materials.
Implementation Method 1
halogenation of 2,4-dimethoxyacetophenone in a mixture of acetonitrile at low temperatures
Implementation Method 2
reaction with dialkyl carbonates in the presence of strong bases to form benzoyl acetates
Data Source
AI summary
The present solution relates to an improved production method of elvitegravir of formula I, which is being clinically evaluated for treatment of HIV infection. Elvitegravir of formula I is produced via the intermediate of formula II, the preparation of which is also an object of the present solution.